ReEx3
1. What was the purpose of the Harrison Act of 1914?
The purpose of the Harrison Act of 1914 was to stop physicians from using opiods to treat patients with opiod addictions.
2. What did methadone clinics do for the stigma of opiod addiction?
In the late 1960’s methadone treatment was limited to specific, highly regulated clinics which only helped to increase the stigma of opiod addiction in the eyes of the general public, the medical community, and in many cases the addicted individuals themselves. Recent changes in federal regulations governing methodone clinics and the introduction of office-based treatment with buprenorphrine have helped lessen some of this stigma, but currently widely used diagnostic schemes continue to support a bias against patients with opiod dependence who are effectively treated.
3. What new medication has lessened the stigma?
Recent changes in federal regulations governing methodone clinics and the introduction of office-based treatment with buprenorphrine have helped lessen some of this stigma, but currently widely used diagnostic schemes continue to support a bias against patients with opiod dependence who are effectively treated
4. What are the problems with the DSM-IV-TR and the ICD-10 in terms of those receiving agonist therapy?
The fact that a patient receiving agonist therapy is doing well and is no longer exhibiting symptoms of Opioid dependence, per DSM-IV-TR or ICD-10, cannot be documented with the clear “in sustained full remission” as it can be with any other substance dependence disorder
5. Does the DSM-IV-TR specify what is considered remission for any of the substance abuse disorders?
For nicotine dependence, DSM-IV-TR appears to allow for an individual to be considered in full, sustained remission whether or not they are taking bupropion.
6. Compare and contrast the DSM-IV-TR and the ICD-10.
Both, the DSM-IV-TH and the ICD-10 are systems to diagnose substance abuse disorders. Both
The purpose of the Harrison Act of 1914 was to stop physicians from using opiods to treat patients with opiod addictions.
2. What did methadone clinics do for the stigma of opiod addiction?
In the late 1960’s methadone treatment was limited to specific, highly regulated clinics which only helped to increase the stigma of opiod addiction in the eyes of the general public, the medical community, and in many cases the addicted individuals themselves. Recent changes in federal regulations governing methodone clinics and the introduction of office-based treatment with buprenorphrine have helped lessen some of this stigma, but currently widely used diagnostic schemes continue to support a bias against patients with opiod dependence who are effectively treated.
3. What new medication has lessened the stigma?
Recent changes in federal regulations governing methodone clinics and the introduction of office-based treatment with buprenorphrine have helped lessen some of this stigma, but currently widely used diagnostic schemes continue to support a bias against patients with opiod dependence who are effectively treated
4. What are the problems with the DSM-IV-TR and the ICD-10 in terms of those receiving agonist therapy?
The fact that a patient receiving agonist therapy is doing well and is no longer exhibiting symptoms of Opioid dependence, per DSM-IV-TR or ICD-10, cannot be documented with the clear “in sustained full remission” as it can be with any other substance dependence disorder
5. Does the DSM-IV-TR specify what is considered remission for any of the substance abuse disorders?
For nicotine dependence, DSM-IV-TR appears to allow for an individual to be considered in full, sustained remission whether or not they are taking bupropion.
6. Compare and contrast the DSM-IV-TR and the ICD-10.
Both, the DSM-IV-TH and the ICD-10 are systems to diagnose substance abuse disorders. Both